Advertisement
Canada markets closed
  • S&P/TSX

    22,308.93
    -66.90 (-0.30%)
     
  • S&P 500

    5,222.68
    +8.60 (+0.16%)
     
  • DOW

    39,512.84
    +125.08 (+0.32%)
     
  • CAD/USD

    0.7315
    +0.0004 (+0.06%)
     
  • CRUDE OIL

    78.20
    -1.06 (-1.34%)
     
  • Bitcoin CAD

    83,256.91
    -2,857.61 (-3.32%)
     
  • CMC Crypto 200

    1,261.13
    -96.88 (-7.13%)
     
  • GOLD FUTURES

    2,366.90
    +26.60 (+1.14%)
     
  • RUSSELL 2000

    2,059.78
    -13.85 (-0.67%)
     
  • 10-Yr Bond

    4.5040
    +0.0550 (+1.24%)
     
  • NASDAQ

    16,340.87
    -5.40 (-0.03%)
     
  • VOLATILITY

    12.55
    -0.14 (-1.10%)
     
  • FTSE

    8,433.76
    +52.41 (+0.63%)
     
  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     
  • CAD/EUR

    0.6789
    +0.0011 (+0.16%)
     

Walgreens stock rises on Q2 earnings, sees decline in COVID-19 testing

Yahoo Finance Live’s Rachelle Akuffo breaks down the rise in stock for Walgreens.

Video Transcript

RACHELLE AKUFFO: All right, turning now to our trending ticker. Walgreens rising after reporting a beat on estimates. The health-focused retailer seeing its business accelerate in February with its health-care unit helping offset a drop in demand it's seeing as COVID-19 cases and demand continue to wane.

Walgreens reporting a decline in both vaccinations and testing. This, of course, leading to decreased foot traffic in its stores.